Logo image of PSTI

PLURISTEM THERAPEUTICS INC (PSTI) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:PSTI - US72940R3003 - Common Stock

1 USD
-0.03 (-2.91%)
Last: 7/25/2022, 8:17:24 PM
1.03 USD
+0.03 (+3%)
After Hours: 7/25/2022, 8:17:24 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to PSTI. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 3.57. This target is 257% above the current price.
  • PSTI was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about PSTI.
  • In the previous month the buy percentage consensus was at a similar level.
  • PSTI was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

PSTI Historical Analyst RatingsPSTI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -67 -61 -55 -49 -43 -37 -31 -25 -19 -13 -7 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 1.003.033.573.574.20 - 203.00% 257.00% 257.00% 320.00%

Related screens

PSTI Current Analyst RatingPSTI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2022-07-20 Alliance Global Partners Maintains Buy
2021-05-04 Alliance Global Partners Initiate Buy

PLURISTEM THERAPEUTICS INC / PSTI FAQ

What is the price target for PSTI stock?

8 analysts have analysed PSTI and the average price target is 3.57 USD. This implies a price increase of 257% is expected in the next year compared to the current price of 1.


What is the consensus rating for PLURISTEM THERAPEUTICS INC (PSTI) stock?

The consensus rating for PLURISTEM THERAPEUTICS INC (PSTI) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.